Dyadic International, Inc. (OTCQX: DYAI)  is a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers to improve access and cost to patients and the healthcare system - but most importantly to save lives.

Biotechnology

Dyadic International

Dyadic International's headquarters in Jupiter, FL, United States

Mark A. Emalfarb

Joe Hazelton

Ping W. Rawson

Ronen Tchelet

Michael P. Tarnok

Arindam Bose

Barry C. Buckland

Patrick Lucy

Seth J. Herbst

The Business Development and Licensing team at Dyadic International is responsible for identifying and pursuing strategic partnerships and licensing opportunities that enhance the company's C1 expression system. They work collaboratively with research and development to align business goals with innovative biotech solutions, aiming to accelerate the development and commercialization of biologic vaccines and drugs. Their efforts are focused on optimizing market access, improving patient outcomes, and driving revenue growth for the company.

Business Development and Licensing

The Finance and Accounting team at Dyadic International is responsible for managing the company's financial health and ensuring compliance with accounting regulations. This team develops financial strategies, oversees budgeting and forecasting, and maintains accurate financial records while implementing internal controls to safeguard company assets. Their efforts support the overall mission of facilitating the development and distribution of life-saving biologic vaccines and drugs.

Finance and Accounting

The Leadership Team at Dyadic International is responsible for driving the company's strategic vision and operational effectiveness. They oversee the integration of innovative biotechnology solutions, including the C1 expression system, to expedite the development and commercialization of biologic vaccines and drugs. This team collaborates across functions to ensure financial stability, foster research and business development, and ultimately enhance patient access to life-saving therapies.

Dyadic International

Org chart

Board & advisors

Teams

Business Development and Licensing

Finance and Accounting

Leadership Team

Offices

Dyadic International

Org chart

Board & advisors

Teams

Business Development and Licensing

Finance and Accounting

Leadership Team

Offices

Related companies